As of November 10, 2026, Neurogene Inc. is a publicly traded company (Nasdaq: NGNE); its largest reported holder is Prudential Financial Inc., with 11.2% on Schedule 13G of October 7, 2026, then Jennison Associates LLC (11.1%) (Schedule 13G, October 7, 2026).
Is this your company?
About to sign with, pay or invest in Neurogene Inc.? See the free Snapshot first.
Free to see. No signup.
Is Neurogene Inc. a real, registered company?
- Neurogene Inc. files with the SEC under CIK 1404644 (its SEC filings).
- Its shares are listed under the ticker NGNE on Nasdaq (SEC company record).
- business address in New York, New York, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Neurogene Inc. in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Christine Mikail, Director (Form 8-K filed 2026-04-20). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Prudential Financial Inc. (filed 2026-10-07).
Who are Neurogene Inc.'s owners and officers?
Neurogene Inc.: business address in New York, New York; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-07).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-07 | Prudential Financial Inc | 11.2% |
| Schedule 13G, 2026-10-06 | Jennison Associates LLC | 11.1% |
| Schedule 13G/A, 2026-08-14 | Trails Edge Capital Partners, LP | 4.5% |
| Schedule 13G/A, 2026-08-14 | Redmile Group, LLC | 9.9% |
| Schedule 13G, 2026-08-14 | Balyasny Asset Management L.P. | 5.18% |
| Schedule 13G/A, 2026-02-17 | Redmile Group, LLC | 9.9% |
| Schedule 13G, 2025-12-15 | Trails Edge Capital Partners, LP | 5.1% |
| Schedule 13G/A, 2025-11-14 | Ecor1 Capital, LLC | 9.9% |
| Schedule 13G/A, 2025-08-14 | Commodore Capital LP | 3% |
| Schedule 13G/A, 2025-08-14 | Baker Bros. Advisors LP | 7% |
Questions about who owns Neurogene Inc.
Who owns Neurogene Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Neurogene Inc.: Prudential Financial Inc (11.2%, Schedule 13G, filed 2026-10-07), Jennison Associates LLC (11.1%, Schedule 13G, filed 2026-10-06), Redmile Group, LLC (9.9%, Schedule 13G/A, filed 2026-08-14), Ecor1 Capital, LLC (9.9%, Schedule 13G/A, filed 2025-11-14) and Baker Bros. Advisors LP (7%, Schedule 13G/A, filed 2025-08-14); 1 more is listed above.
Who are the largest shareholders of Neurogene Inc.?
By the share each holder's latest filing reports, the largest holders of Neurogene Inc. on this page are Prudential Financial Inc (11.2%), Jennison Associates LLC (11.1%) and Redmile Group, LLC (9.9%).
When did Prudential Financial Inc buy into Neurogene Inc.?
The filings give report dates, not purchase dates. The earliest filing from Prudential Financial Inc on this page is the Schedule 13G, filed 2026-10-07, reporting 11.2%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Neurogene Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Neurogene Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neurogene Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-20 | Christine Mikail | Director | appointed |
Which insiders own Neurogene Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Samsara BioCapital GP, LLC, a 10% owner: 1,717,127 shares (8.3% of shares outstanding), held indirectly through By Samsara BioCapital, L.P., on a joint filing (Form 4, 2024-11-27).
- , a 10% owner: 1,717,127 shares (8.3% of shares outstanding), held indirectly through By Samsara BioCapital, L.P., on a joint filing (Form 4, 2024-11-27).
- , L.P., a 10% owner: 1,717,127 shares (8.3% of shares outstanding), held indirectly through By Samsara BioCapital, L.P., on a joint filing (Form 4, 2024-11-27).
- , the chief executive and a director: 1,345,063 shares (6.5% of shares outstanding) (Form 4, 2026-10-02).
- , the president and chief financial officer: 84,040 shares (0.41% of shares outstanding) (Form 4, 2026-07-07).
Shares outstanding: 20,700,905 as of 2026-11-05, from the company's latest SEC cover page.
How much has Neurogene Inc. raised?
Latest IPO step: Neurogene Inc. filed to go public (S-1, 2024-12-02).
IPO filings: S-1, 2024-12-02.
Keep reading
More on Neurogene Inc. and the records around it.
Neurogene Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Apr 2026
Companies that share a holder
- Jennison Associates LLC also filed stake reports on 14 other companies: LENDINGTREE INC (Oct 2026), PALVELLA THERAPEUTICS INC (Oct 2026), REZOLUTE INC (Oct 2026)
- Trails Edge Capital Partners, LP also filed stake reports on 16 other companies: Avalo Therapeutics, Inc. (Oct 2026), Sol-Gel Technologies Ltd. (Oct 2026), Contineum Therapeutics, Inc. (Oct 2026)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Nurix Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/neurogene